Riskpilot← Back to searchSign inGet full accessKOPPERNÆS PROTEIN AS
ASActiveOrg 925418498Breivika Industriveg 4, 6018 ÅlesundRental and operating of own or leased real estate · NACE 6820Est. 20200 employees
Revenue 2024
NOK 0
EBITDA margin
—
-6% vs 2023
Equity ratio
29.5%
Financial strength
Net profit 2024
NOK -50,3M
-121% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -2,7M | -6% |
| Net profit | NOK -50,3M | -121% |
| Total assets | NOK 2,1B | -5% |
| Equity | NOK 617,4M | -23% |
| Employees | 0 | — |
Legal name
KOPPERNÆS PROTEIN AS
Org number
925418498
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
31. juli 2020
Share capital
NOK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Eie aksjer og finansiere selskaper som driver produksjon av og handel med fòr og fòrtilsetningsstoffer, samt annen virksomhet som det er naturlig å utøve i forbindelse hermed.
Address
Breivika Industriveg 4, 6018 Ålesund
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −23 | −978 | −2 376 | −2 516 | −2 669 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −23 | −978 | −2 376 | −2 516 | −2 669 |
| Net financials | −65 533 | 157 067 | 202 066 | 237 042 | −61 799 |
| Profit before tax | −65 556 | 156 089 | 199 690 | 234 526 | −64 468 |
| Tax | 9 830 | 8 665 | −68 | −55 | −14 183 |
| Net profit | −75 386 | 147 424 | 199 758 | 234 581 | −50 285 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 584 692 | 1 212 744 | 1 550 818 | 2 190 981 | 2 091 876 |
| Equity | 219 353 | 363 646 | 563 404 | 797 985 | 617 374 |
| Long-term debt | 809 656 | 674 814 | 767 073 | 752 258 | 759 962 |
| Short-term debt | 555 684 | 174 283 | 220 342 | 640 739 | 714 540 |
| Total debt | 1 365 340 | 849 097 | 987 415 | 1 392 997 | 1 474 502 |
EBITDA margin
-266900000.0%
This company
15.8%
Market median
-1689240606% vs market
20202024
Equity ratio
29.5%
This company
38.2%
Market median
-23% vs market
20202024
Return on equity
-8.1%
This company
18.4%
Market median
-144% vs market
20202024
Net profit margin
-5028500000.0%
This company
8.1%
Market median
-62080247014% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
2.39×
This company
0.62×
Market median
-285% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KL Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Koppernæs As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Stella Holding I As
KOPPERNÆS PROTEIN AS Board members of KOPPERNÆS PROTEIN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kenneth Lande Klokk | Chief Executive Officer | 0 companies |
| Bjarte Andreassen | Board of Directors | 0 companies |
| Hans Peter Koppernæs | Board of Directors | 0 companies |